Showing results (391-400 of 422) with videos related to
Sort By:
Pageof 43
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 21, 2023
Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: Perioperative and long-term results from a propensity-score based studyGiorgio Bogani, Violante Di Donato, Andrea Papadia, et al.British Journal of Haematology|April 29, 2025
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national databaseMaddalena Casale, Raffaella Colombatti, Manuela Balocco, et al.The Lancet. Haematology|December 28, 2020
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trialMarco Ladetto, Sergio Cortelazzo, Simone Ferrero, et al.Cancers|January 11, 2022
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Simone Ferrero, Eva Hoster, et al.Blood Advances|January 14, 2025
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trialSimone Ragaini, Anna Galli, Elisa Genuardi, et al.Haematologica|September 21, 2019
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Davide Rossi, Andrea Rinaldi, et al.Leukemia|November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trialMouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.Oncotarget|May 29, 2018
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphomaAlessandro Broccoli, Beatrice Casadei, Alice Morigi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2021
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 StudyStefano Luminari, Martina Manni, Sara Galimberti, et al.British Journal of Haematology|May 14, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53)Miguel Bastos-Boente, Alejandro Medina-Herrera, Almudena Navarro-Bailón, et al.Pageof 43